131 related articles for article (PubMed ID: 9048763)
21. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.
Cáceres J; Brandan E
J Cell Biochem; 1997 May; 65(2):145-58. PubMed ID: 9136074
[TBL] [Abstract][Full Text] [Related]
22. Mutation of potential N-linked glycosylation sites in the Alzheimer's disease amyloid precursor protein (APP).
Yazaki M; Tagawa K; Maruyama K; Sorimachi H; Tsuchiya T; Ishiura S; Suzuki K
Neurosci Lett; 1996 Dec; 221(1):57-60. PubMed ID: 9014180
[TBL] [Abstract][Full Text] [Related]
23. Characterization of beta-amyloid peptide precursor processing by the yeast Yap3 and Mkc7 proteases.
Zhang W; Espinoza D; Hines V; Innis M; Mehta P; Miller DL
Biochim Biophys Acta; 1997 Nov; 1359(2):110-22. PubMed ID: 9409808
[TBL] [Abstract][Full Text] [Related]
24. APP-collagen interaction is mediated by a heparin bridge mechanism.
Breen KC
Mol Chem Neuropathol; 1992; 16(1-2):109-21. PubMed ID: 1520400
[TBL] [Abstract][Full Text] [Related]
25. Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein.
Tomita S; Ozaki T; Taru H; Oguchi S; Takeda S; Yagi Y; Sakiyama S; Kirino Y; Suzuki T
J Biol Chem; 1999 Jan; 274(4):2243-54. PubMed ID: 9890987
[TBL] [Abstract][Full Text] [Related]
26. The beta-amyloid domain is essential for axonal sorting of amyloid precursor protein.
Tienari PJ; De Strooper B; Ikonen E; Simons M; Weidemann A; Czech C; Hartmann T; Ida N; Multhaup G; Masters CL; Van Leuven F; Beyreuther K; Dotti CG
EMBO J; 1996 Oct; 15(19):5218-29. PubMed ID: 8895567
[TBL] [Abstract][Full Text] [Related]
27. A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.
Ghiso J; Rostagno A; Gardella JE; Liem L; Gorevic PD; Frangione B
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1053-9. PubMed ID: 1281980
[TBL] [Abstract][Full Text] [Related]
28. The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96-110.
Corrigan F; Thornton E; Roisman LC; Leonard AV; Vink R; Blumbergs PC; van den Heuvel C; Cappai R
J Neurochem; 2014 Jan; 128(1):196-204. PubMed ID: 23919582
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.
Lahiri DK; Ge YW; Maloney B
FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.
Kerr ML; Small DH
J Neurosci Res; 2005 Apr; 80(2):151-9. PubMed ID: 15672415
[TBL] [Abstract][Full Text] [Related]
31. Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease.
Okamoto T; Takeda S; Giambarella U; Murayama Y; Matsui T; Katada T; Matsuura Y; Nishimoto I
EMBO J; 1996 Aug; 15(15):3769-77. PubMed ID: 8670881
[TBL] [Abstract][Full Text] [Related]
32. The beta A4 amyloid precursor protein binding to copper.
Hesse L; Beher D; Masters CL; Multhaup G
FEBS Lett; 1994 Jul; 349(1):109-16. PubMed ID: 7913895
[TBL] [Abstract][Full Text] [Related]
33. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
[TBL] [Abstract][Full Text] [Related]
34. The E2 domains of APP and APLP1 share a conserved mode of dimerization.
Lee S; Xue Y; Hu J; Wang Y; Liu X; Demeler B; Ha Y
Biochemistry; 2011 Jun; 50(24):5453-64. PubMed ID: 21574595
[TBL] [Abstract][Full Text] [Related]
35. Size and sulfation are critical for the effect of heparin on APP processing and Aβ production.
Cui H; Hung AC; Freeman C; Narkowicz C; Jacobson GA; Small DH
J Neurochem; 2012 Nov; 123(3):447-57. PubMed ID: 22909067
[TBL] [Abstract][Full Text] [Related]
36. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
37. Proteolysis of Alzheimer's disease beta-amyloid precursor protein by factor Xa.
Haas C; Aldudo J; Cazorla P; Bullido MJ; de Miguel C; Vázquez J; Valdivieso F
Biochim Biophys Acta; 1997 Nov; 1343(1):85-94. PubMed ID: 9428662
[TBL] [Abstract][Full Text] [Related]
38. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
Buée L; Ding W; Delacourte A; Fillit H
Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
[TBL] [Abstract][Full Text] [Related]
39. Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease.
Golde TE; Cai XD; Shoji M; Younkin SG
Ann N Y Acad Sci; 1993 Sep; 695():103-8. PubMed ID: 8239266
[TBL] [Abstract][Full Text] [Related]
40. Missense mutations associated with familial Alzheimer's disease in Sweden lead to the production of the amyloid peptide without internalization of its precursor.
Essalmani R; Macq AF; Mercken L; Octave JN
Biochem Biophys Res Commun; 1996 Jan; 218(1):89-96. PubMed ID: 8573182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
